142 related articles for article (PubMed ID: 35520297)
21. Evaluation of 68Ga-labeled MG7 antibody: a targeted probe for PET/CT imaging of gastric cancer.
Xu B; Li X; Yin J; Liang C; Liu L; Qiu Z; Yao L; Nie Y; Wang J; Wu K
Sci Rep; 2015 Mar; 5():8626. PubMed ID: 25733152
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, preclinical evaluation, and a pilot clinical imaging study of [
Xie Q; Liu T; Ding J; Zhou N; Meng X; Zhu H; Li N; Yu J; Yang Z
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3129-3140. PubMed ID: 33630145
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of (68)Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging.
Yu HM; Chen JH; Lin KL; Lin WJ
J Labelled Comp Radiopharm; 2015 Jun; 58(7):299-303. PubMed ID: 25997858
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, Radiolabeling, and Preliminary in vivo Evaluation of [
Farn SS; Chang KW; Lin WC; Yu HM; Lin KL; Tseng YC; Chang Y; Yu CS; Lin WJ
Drug Des Devel Ther; 2021; 15():2577-2591. PubMed ID: 34168430
[TBL] [Abstract][Full Text] [Related]
25. One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging.
Liu S; Liu H; Jiang H; Xu Y; Zhang H; Cheng Z
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1732-41. PubMed ID: 21617974
[TBL] [Abstract][Full Text] [Related]
26. Syntheses and Preliminary Evaluation of Dual Target PET Probe [18F]-NOTA-Gly3- E (2PEG4-RGD-WH701) for PET Imaging of Breast Cancer.
Chen Z; Fu H; Wu H; Huang J; Yao L; Zhang X; Li Y
Anticancer Agents Med Chem; 2020; 20(13):1548-1557. PubMed ID: 32329699
[TBL] [Abstract][Full Text] [Related]
27. A novel facile method of labeling octreotide with (18)F-fluorine.
Laverman P; McBride WJ; Sharkey RM; Eek A; Joosten L; Oyen WJ; Goldenberg DM; Boerman OC
J Nucl Med; 2010 Mar; 51(3):454-61. PubMed ID: 20150268
[TBL] [Abstract][Full Text] [Related]
28. [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation.
Knetsch PA; Zhai C; Rangger C; Blatzer M; Haas H; Kaeopookum P; Haubner R; Decristoforo C
Nucl Med Biol; 2015 Feb; 42(2):115-22. PubMed ID: 25459110
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Evaluation of a Novel
Zhang H; Kanduluru AK; Desai P; Ahad A; Carlin S; Tandon N; Weber WA; Low PS
Bioconjug Chem; 2018 Apr; 29(4):1319-1326. PubMed ID: 29466853
[TBL] [Abstract][Full Text] [Related]
30. Clinical Translation of [
Xavier C; Blykers A; Laoui D; Bolli E; Vaneyken I; Bridoux J; Baudhuin H; Raes G; Everaert H; Movahedi K; Van Ginderachter JA; Devoogdt N; Caveliers V; Lahoutte T; Keyaerts M
Mol Imaging Biol; 2019 Oct; 21(5):898-906. PubMed ID: 30671739
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals.
Ferreira CL; Lamsa E; Woods M; Duan Y; Fernando P; Bensimon C; Kordos M; Guenther K; Jurek P; Kiefer GE
Bioconjug Chem; 2010 Mar; 21(3):531-6. PubMed ID: 20175523
[TBL] [Abstract][Full Text] [Related]
32. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
[TBL] [Abstract][Full Text] [Related]
33. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
Chakraborty S; Sarma HD; Vimalnath KV; Pillai MR
Nucl Med Biol; 2013 Oct; 40(7):946-54. PubMed ID: 23850487
[TBL] [Abstract][Full Text] [Related]
34. First
Poschenrieder A; Osl T; Schottelius M; Hoffmann F; Wirtz M; Schwaiger M; Wester HJ
Tomography; 2016 Jun; 2(2):85-93. PubMed ID: 30042959
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
36. PET imaging of a
Xu Y; Wang L; Pan D; Yu C; Mi B; Huang Q; Sheng J; Yan J; Wang X; Yang R; Yang M
Br J Radiol; 2019 Dec; 92(1104):20190425. PubMed ID: 31593482
[TBL] [Abstract][Full Text] [Related]
37. Construction of
Chen Q; Zhang J; Huang M; Wang P; Zhang X; Ma M
Hell J Nucl Med; 2023; 26(2):114-122. PubMed ID: 37527047
[TBL] [Abstract][Full Text] [Related]
38. Detecting Vulnerable Atherosclerotic Plaques by
Jiang L; Zhu H; Li Y; Wu X; Wang H; Cheng Z
Mol Pharm; 2019 Mar; 16(3):1350-1357. PubMed ID: 30742442
[TBL] [Abstract][Full Text] [Related]
39. MicroPET/CT imaging of αvβ₃ integrin via a novel ⁶⁸Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction.
Menichetti L; Kusmic C; Panetta D; Arosio D; Petroni D; Matteucci M; Salvadori PA; Casagrande C; L'Abbate A; Manzoni L
Eur J Nucl Med Mol Imaging; 2013 Aug; 40(8):1265-74. PubMed ID: 23674206
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
